Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Victory International USIFX
- NAV / 1-Day Return 28.07 / +1.23 %
- Total Assets 2.6 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.080%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 3,000
- Status Open
- TTM Yield 1.76%
- Turnover 34%
USD | NAV as of Jul 27, 2024 | 1-Day Return as of Jul 27, 2024, 12:16 AM GMT+0
Morningstar’s Analysis USIFX
Will USIFX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 15.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 2.89 | 73.6 Mil | Healthcare |
Novartis AG Registered Shares | 2.13 | 54.1 Mil | Healthcare |
Shell PLC | 1.64 | 41.6 Mil | Energy |
Nestle SA | 1.39 | 35.3 Mil | Consumer Defensive |
Cash | 1.34 | 34.2 Mil | Cash and Equivalents |
Roche Holding AG | 1.34 | 34.0 Mil | Healthcare |
Toyota Motor Corp | 1.33 | 33.7 Mil | Consumer Cyclical |
SAP SE | 1.32 | 33.5 Mil | Technology |
Siemens AG | 1.22 | 31.2 Mil | Industrials |
ING Groep NV | 1.20 | 30.4 Mil | Financial Services |